本页面由Tiger Trade Technology Pte. Ltd.提供服务

Forte BioSciences Inc

31.43
+0.15000.48%
盘后31.430.00000.00%17:36 EDT
成交量:20.18万
成交额:618.16万
市值:6.16亿
市盈率:-6.67
高:31.57
开:30.91
低:29.76
收:31.28
52周最高:35.80
52周最低:4.90
股本:1,959.56万
流通股本:1,651.21万
量比:0.21
换手率:1.22%
股息:- -
股息率:- -
每股收益(TTM):-4.7137
每股收益(LYR):-12.1671
净资产收益率:-122.28%
总资产收益率:-61.19%
市净率:10.10
市盈率(LYR):-2.58

数据加载中...

2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/11

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/11

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/10

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/04

重要事件披露

Form 8-K - Current report
2023/08/03

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/02

重要事件披露

Form 8-K - Current report
2023/07/07

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/27

重要事件披露

Form 8-K - Current report
2023/05/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/01

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/04/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/31

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/31

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/31

重要事件披露

8-K - Current report
2023/03/29

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/09

重要事件披露

8-K - Current report